the present invention relates to methods and products for the evaluation of hiv treatment . the methods are based on evaluating molecular events at the hiv integrase resulting in altered therapeutic efficacy of the investigated compounds . the methods rely on providing an integrase gene and evaluating either through genotyping or phenotyping said integrase gene . the present invention relates to the fields of diagnostics , drug screening , pharmacogenetics and drug development .